Today

Agents

Chat

Arena

Discover

More

App

Ligand Pharmaceuticals Q2 EPS USD 2.22 - LGND News | Rallies

Ligand Pharmaceuticals Q2 EPS USD 2.22

LGND•2026-08-06

Q2 financial results

Aug. 6 (Reuters) - Ligand Pharmaceuticals reported second-quarter operating income of USD 8.591 million.

Q2 net income: USD 48.508 million
Q2 pretax profit: USD 64.304 million
Q2 basic EPS: USD 2.42

Related News

Zillow: US home sales rise 7% in July as pending listings slump 7.7% from June

ZG•2026-08-06

Burford Capital announces availability of 2Q26 financial results press release

BUR•2026-08-06

Marcus & Millichap Q2 Revenue USD 202.915 Million

2026-08-06

Sandisk Corporation <SNDK.O>: Raymond James Raises Target Price to $2,000 From $1,470

SNDK•2026-08-06

Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand

NVAX•2026-08-06